Logo
Banner

IITZ-01

Cat No.:
LIA014
Price:
Chemical Structure:

Product Information of IITZ-01

Purity
0.9905
Molecular Weight
482.51
Formula
C26H23FN8O
CAS Number
1807988-47-1
Pack Size
Free Sample (0.1-0.5 mg)
10 mM * 1 mL in DMSO
5 mg/10 mg/50 mg/100 mg/200 mg/500 mg
IC50
2.62 μM
Target
PI3Kγ
Applications
IITZ-01 is a potent lysosomotropic autophagy inhibitor with single-agent antitumor activity.
Shelf-Life
Powder:
-20°C, 3 years.
4°C, 2 years.

In solvent:
-80°C, 6 months.
-20°C, 1 month.
Shipping Conditions
Room temperature in continental US, may vary elsewhere.
In Vitro Studies
IITZ-01 (0-2 μM, 24 h) enhances autophagosomes formation as indicated by increased expression of LC3-II levels time- and dose-dependently in triple-negative breast cancer (TNBC) cell lines (MDA-MB-231 and MDA-MB-453). IITZ-01 also demonstrates potent autophagy inhibitory activity in other breast, lung, and colon cancer cells.
In Vivo Studies
IITZ-01 (45 mg/kg, i.p. every alternate day for 4 weeks) inhibits average breast tumor growth when compared with control from third day of treatment in triple-negative breast tumor models in mice.

For research use only, not intended for any clinical use.